Candela's new GentleYAG laser receives FDA Clearance
Gerard E. Puorro, Candela's President and CEO, commented: "FDA clearance for the GentleYAG laser is very significant for the laser hair removal market. This is our first laser that completely meets the hair removal needs of darker skinned persons, while being entirely suitable for all skin types. The laser is smaller, lighter, more affordable, and easier to use than what was previously available. It will improve the in-office hair removal capabilities of physicians and other practitioners."
The GentleYAG rounds out Candela's family of hair reduction lasers, which includes the industry-leading GentleLASE(TM) Plus and the new GentleLASE Limited Edition(TM) (LE) alexandrite lasers, offering permanent hair reduction. Candela President Puorro summed up: "This laser is another sign of Candela's ongoing commitment to providing the market with safe, effective, versatile, and affordable hair removal lasers for a wide variety of patient skin types and practitioner needs."
About Candela:
Candela Corporation develops, manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using aesthetic laser systems and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 50 countries from offices in the United States, Europe, and Asia. Candela established the aesthetic laser market 12 years ago, and currently has an installed base of over 4,000 lasers worldwide. Candela is an Equal Opportunity and Affirmative Action Employer, M/F/H/V. For more about Candela, visit the company's web site at www.clzr.com.
Subscribe to our free e-mail newsletter.
Click for a free Buyer's Guide listing.